Back
Top 52%
12.0%
Top 12%
12.0%
Top 2%
11.2%
Top 12%
7.9%
Top 2%
6.5%
Top 1%
6.0%
Top 11%
3.9%
Top 7%
3.9%
Top 2%
3.2%
Top 2%
2.8%
Top 9%
2.0%
Top 2%
2.0%
Top 48%
2.0%
Top 5%
1.6%
Top 7%
1.2%
Top 5%
1.2%
Top 10%
1.2%
Top 0.3%
1.0%
Top 4%
1.0%
Top 4%
1.0%
Top 20%
0.7%
Top 21%
0.7%
Top 8%
0.7%
Top 16%
0.5%
I3LUNG: Clinical Validation of a Multimodal AI Tool to Support Immunotherapy Decisions in NSCLC
2026-01-22
oncology
Title + abstract only
View on medRxiv
Show abstract
Despite a decade of immunotherapy, treatment selection in non-small cell lung cancer (NSCLC) still relies on subgroup analyses and clinical scores. I3LUNG (NCT05537922) is currently the largest international, real-world, multimodal, artificial intelligence (AI)-based trial, enrolling 2365 patients. We integrated real-world clinical data (RWD), computed tomography (CT) images, digital pathology (DP), and genomics (G) into machine learning early-fusion (MLEF) and deep-learning intermediate-fusion ...
Predicted journal destinations
1
PLOS ONE
1737 training papers
2
Scientific Reports
701 training papers
3
Cancers
57 training papers
4
Nature Communications
483 training papers
5
Frontiers in Oncology
34 training papers
6
Clinical Cancer Research
22 training papers
7
eLife
262 training papers
8
npj Digital Medicine
85 training papers
9
Cancer Medicine
17 training papers
10
British Journal of Cancer
22 training papers
11
JAMA Network Open
125 training papers
12
BMC Cancer
21 training papers
13
BMJ Open
553 training papers
14
Nature Medicine
88 training papers
15
Computers in Biology and Medicine
39 training papers
16
JAMIA Open
35 training papers
17
PLOS Computational Biology
141 training papers
18
PNAS Nexus
22 training papers
19
Diagnostics
36 training papers
20
Communications Medicine
63 training papers
21
Proceedings of the National Academy of Sciences
100 training papers
22
Journal of Medical Internet Research
81 training papers
23
PeerJ
46 training papers
24
iScience
74 training papers